Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Swedberg

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Lakartidningen|November 22, 1978
[Pathophysiology of left ventricular failure]K Swedberg
Drugs|January 1, 1994
Exercise testing in heart failure. A critical reviewK Swedberg
Evidence-Based Cardiovascular Medicine|June 1, 1997
Digoxin did not reduce mortality but reduced the rate of hospitalization due to worsening heart failure among patients with heart failureK Swedberg
Journal of Human Hypertension|July 26, 2002
Current perspectives for AT(1)-receptor blockers in the management of heart failureK Swedberg
Heart (British Cardiac Society)|August 24, 2000
The future: cardiovascular medicine in 10 yearsK Swedberg
Lakartidningen|October 3, 1973
[2 cases of cardiogenic shock in acute heart infarct treated with large doses of corticosteroids]K Swedberg
European Journal of Heart Failure|August 12, 2000
Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategiesK Swedberg
Lakartidningen|November 16, 1977
[Cardiomyopathy--a neglected diagnosis?]K Swedberg
Lakartidningen|July 14, 1999
[Beta-blockers in heart failure. From contraindicated therapy to the best documented one]K Swedberg
Journal of Cardiovascular Risk|October 9, 1999
Beta-blockers and heart failureK Swedberg
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Lakartidningen|November 22, 1978
[Pathophysiology of left ventricular failure]K Swedberg
Drugs|January 1, 1994
Exercise testing in heart failure. A critical reviewK Swedberg
Evidence-Based Cardiovascular Medicine|June 1, 1997
Digoxin did not reduce mortality but reduced the rate of hospitalization due to worsening heart failure among patients with heart failureK Swedberg
Journal of Human Hypertension|July 26, 2002
Current perspectives for AT(1)-receptor blockers in the management of heart failureK Swedberg
Heart (British Cardiac Society)|August 24, 2000
The future: cardiovascular medicine in 10 yearsK Swedberg
Lakartidningen|October 3, 1973
[2 cases of cardiogenic shock in acute heart infarct treated with large doses of corticosteroids]K Swedberg
European Journal of Heart Failure|August 12, 2000
Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategiesK Swedberg
Lakartidningen|November 16, 1977
[Cardiomyopathy--a neglected diagnosis?]K Swedberg
Lakartidningen|July 14, 1999
[Beta-blockers in heart failure. From contraindicated therapy to the best documented one]K Swedberg
Journal of Cardiovascular Risk|October 9, 1999
Beta-blockers and heart failureK Swedberg
Pageof 22